logo
Plus   Neg
Share
Email

ReneSola Q2 Profit Declines, Revenues Nearly Double - Quick Facts

Solar project developer ReneSola Ltd. (SOL) reported Thursday that net income attributed to ReneSola for the second quarter declined to $3.09 million or $0.06 per share from $5.12 million or $0.13 per share in prior-year quarter.

Excluding items, adjusted net income attributed to ReneSola was $3.64 million or $0.08 per share, compared to $4.97 million or $0.13 per share in year-ago quarter.

However, revenue for the quarter nearly doubled to $26.19 million from $13.57 million in the same quarter last year.

Looking ahead, the company projects revenue for the third quarter in a range of $8 million to $10 million and continues to expect revenue for the full-year 2020 in the range of $80 million to $100 million.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Walmart and Sam's Club announced options for customers to safely dispose unused, unwanted and expired medication throughout the year. With this, the retail giant aims to help the public from potential danger for misuse and abuse of prescription medications. On Saturday, October 24, the company will host in-person medication disposal events at select store and club locations across U.S. Telecom giant AT&T, Inc. reported Thursday a 24 percent decline in profit for the third quarter, primarily hurt by lower revenues across all its operating segments amid the impact from COVID-19 pandemic. Adjusted earnings for the quarter met analysts' expectations, while quarterly revenues topped their estimates. A Brazilian volunteer, who participated in a clinical trial of the COVID-19 vaccine developed by AstraZeneca and Oxford University, has died, Brazilian health authority Anvisa said. Oxford university reportedly confirmed the plan to continue the trial after careful assessment that there have been no concerns about safety of the clinical trial.
Follow RTT